These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36586636)

  • 1. pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy.
    Ghosh N; Kundu M; Ghosh S; Das AK; De S; Das J; Sil PC
    Int J Pharm; 2023 Jan; 631():122555. PubMed ID: 36586636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency.
    Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic Acid-Polyethyleneimine Functionalized Mesoporous Silica Nanoparticles as a Controlled Release Nanocarrier.
    Park J; Park SS; Jo NJ; Ha CS
    J Nanosci Nanotechnol; 2019 Oct; 19(10):6217-6224. PubMed ID: 31026940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
    Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
    Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
    Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
    Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
    Saroj S; Rajput SJ
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of anti-neoplastic effects of cuminaldehyde against breast cancer via mesoporous silica nanoparticle based targeted drug delivery system.
    Ghosh S; Kundu M; Dutta S; Mahalanobish S; Ghosh N; Das J; Sil PC
    Life Sci; 2022 Jun; 298():120525. PubMed ID: 35378139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Characterization and Safety Evaluation of Folic Acid-conjugated Mesoporous Silica Nanoparticles Loaded with Rhodojaponin III.
    Yang Q; Zhao C; Yang J; Zhao J; Feng Y; Liu M; Zhang J
    Curr Drug Deliv; 2023; 20(10):1559-1568. PubMed ID: 36366851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
    Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
    Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy.
    Wang J; Wang Y; Liu Q; Yang L; Zhu R; Yu C; Wang S
    ACS Appl Mater Interfaces; 2016 Oct; 8(40):26511-26523. PubMed ID: 27619078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
    Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
    Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
    Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 18. Monodisperse Rattle-Structured Gold Nanorod-Mesoporous Silica Nanoparticles Core-Shell as Sulforaphane Carrier and its Sustained-Release Property.
    Manjili HK; Ma'mani L; Naderi-Manesh H
    Drug Res (Stuttg); 2018 Sep; 68(9):504-513. PubMed ID: 29660748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.
    Pourjavadi A; Tehrani ZM; Moghanaki AA
    Pharm Res; 2016 Feb; 33(2):417-32. PubMed ID: 26438181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo therapeutic evaluation of a novel bis-lawsone derivative against tumor following delivery using mesoporous silica nanoparticle based redox-responsive drug delivery system.
    Kundu M; Sadhukhan P; Ghosh N; Ghosh S; Chatterjee S; Das J; Brahmachari G; Sil PC
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112142. PubMed ID: 34082953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.